-
CSR Summary Not Yet Available
-
NCT00210808
-
Primary Citation
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment407% Female84.2%% White75.7%
Product ClassAnticonvulsantsSponsor Protocol NumberCAPSS-220Data PartnerJohnson & JohnsonCondition StudiedObesityMean/Median Age (Years)44
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0580 : Developing approaches to accelerate clinical trials using real world data (RWD) from electronic health records (EHR)
- 2023-5486 : Incorporating external data in clinical trial setting using BART
- 2020-4276 : Psychiatric Symptoms as Adverse Events of Topiramate Therapy: Systematic Review and Meta-Analysis